A Study of LY3526318 in Healthy Participants

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
The main purpose of this study is to learn more about the safety and side effects of LY3526318 when given by mouth to healthy participants. The study will have two parts. Each participant will enroll in only one part. For each participant, Part A will last up to 28 days and Part B will last up to 51 days, including screening and follow‐up.
Epistemonikos ID: 5eecdbe49ae5478d3a5c81b77fcb7a88bc2c14bb
First added on: May 22, 2024